M&A
Century Textiles to hive off cement business, sell it to UltraTech
21 May 2018
Aditya Birla Group firm UltraTech will acquire the cement business of BK Birla Group company Century Textiles and Industries through a share swap deal in which shareholders of Century Textiles will get one equity share of UltraTech for every eight equity shares held
Tata Steel completes acquisition of bankrupt Bhushan Steel
19 May 2018
Tata Steel said on Friday it has completed the acquisition of a 72.7 per cent stake in bankrupt Bhushan Steel Ltd (BSL) for Rs35,200 crore, making the first acquisition of a stressed asset under the new Insolvency and Bankruptcy Code
RCom, Ericsson propose to settle matter out of NCLT
17 May 2018
Creditor banks are reported to be backing the debt-ridden telco to counter Swedish gear maker Ericsson’s move in order to ensure that their dues are not compromised
ArcelorMittal deposits Rs7,000 cr with SBI to ensure eligibility for Essar
16 May 2018
The move to park about Rs7,000 crore in an escrow account of State Bank of India follows ArcelorMittal's bid for Essar Steel being questioned because of its past shareholding in loan defaulter Uttam Galva Steel
Bharti Airtel-Telenor merger finalised as DoT gives nod
15 May 2018
Airtel will formally buy Telenor India in a no-cash deal and take over its spectrum payment dues of about Rs1,650 crore. All customers of Telenor India would become part of Airtel, which will get 43.4 MHz of spectrum in the 1,800 MHz band from Telenor
NCLT approves Tata Steel as the owner of Bhushan Steel
15 May 2018
The National Company Law Tribunal (NCLT) on Tuesday approved Tata Steel’s bid to take over debt-ridden Bhushan Steel
Aurobindo and others in the race to buy Novartis portfolio of US assets
12 May 2018
If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal
Eli Lilly to buy Armo BioSciences for $1.6 bn
11 May 2018
US pharmaceutical company Eli Lilly and Co yesterday struck a deal to buy Armo BioSciences Inc for about $1.6 billion in order to strengthen its immuno-oncology portfolio